Present status of polysaccharide vaccines in the prevention of meningococcal disease.
D000293:Adolescent; D000328:Adult; D000367:Age Factors; D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines / Q000008:administration & dosage / Q000009:adverse effects; D002648:Child; D002675:Child, Preschool; D004926:Escherichia coli / Q000276:immunology; D006801:Humans; D007109:Immunity; D007115:Immunization Schedule; D007223:Infant; D008589:Meningococcal Infections / Q000276:immunology / Q000517:prevention & control*; D008970:Molecular Weight; D009345:Neisseria meningitidis / Q000276:immunology; D011018:Pneumonia, Pneumococcal / Q000517:prevention & control; D011135:Polysaccharides, Bacterial / Q000276:immunology; D013296:Streptococcus pneumoniae
D000907:Antibodies, Bacterial; D001428:Bacterial Vaccines; D011135:Polysaccharides, Bacterial